Vydate 10G

Primær information

  • Handelsnavn:
  • Vydate 10G Granulat
  • Lægemiddelform:
  • Granulat
  • Sammensætning:
  • 100 g/kg oxamyl
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

Lokation

  • Fås i:
  • Vydate 10G Granulat
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Sidste ændring:
  • 08-02-2018

Produktresumé

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

This SDS adheres to the standards and regulatory requirements of Great Britain and may not meet the regulatory

requirements in other countries.

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING

Product information

Product name

VYDATE

10 G

Synonyms

B10049174

Use of the

Substance/Preparation

insecticide

Company

Du Pont (U.K.) Limited

Wedgwood Way

SG1 4QN Stevenage

+4401438734450

Telefax

Emergency telephone

number

+44-(0)2871-861.313

2. COMPOSITION/INFORMATION ON INGREDIENTS

Chemical Name

CAS-No.

EC-No.

Classification

Concentration [%]

Oxamyl

23135-22-0

T+; R26/28

Xn; R21

N; R51

CYCLOHEXANONE

108-94-1

203-631-1

Xn; R20

5 - 7

Phosphoric acid

7664-38-2

231-633-2

C; R34

3 - 4,5

For the full text of the R phrases mentioned in this Section, see Section 16.

3. HAZARDS IDENTIFICATION

Toxic by inhalation and if swallowed.

Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.

4. FIRST AID MEASURES

General advice

Call a physician or Poison Control Centre immediately. This product contains an

anticholinesterase compound. Do not use if under medical advice not to work

with such compounds. Never give anything by mouth to an unconscious person.

If breathing is irregular or stopped, administer artificial respiration. For specialist

advice physicians should contact the National Poisons Information Service, (24-

hr), Tel: 0870-600-6266.

Inhalation

Move to fresh air. If victim is unconscious but breathing: Give oxygen.

Skin contact

Wash off immediately with soap and plenty of water. Take off contaminated

Print date: 2005 - 2 - 10

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

clothing and shoes immediately. If skin irritation persists, call a physician.

Eye contact

Rinse thoroughly with plenty of water, also under the eyelids. Keep eye wide

open while rinsing. If eye irritation persists, consult a specialist.

Ingestion

Drink 1 or 2 glasses of water. Do not induce vomiting without medical advice.

Notes to physician

Symptoms

constriction of pupils, blurred vision, Daze, Breathing difficulties, sweating, slow

pulse, muscle twitching, weakness, headache

Risks

This product is a cholinesterase inhibitor carbamate.

Treatment

Administer atropine sulphate as antidote. bis zur völligen Atropisierung

Morphine, 2-PAM and oxime therapy are contra-indicated.

5. FIRE-FIGHTING MEASURES

Suitable extinguishing

media

water spray, foam, dry chemical, carbon dioxide (CO2),

Extinguishing media which

must not be used for safety

reasons

high volume water jet, (contamination risk),

Special protective

equipment for fire-fighters

In the event of fire, wear self-contained breathing apparatus.

Further information

(on small fires) If area is heavily exposed to fire and if conditions permit, let fire

burn itself out since water may increase the area contaminated. Cool containers

/ tanks with spray water.

6. ACCIDENTAL RELEASE MEASURES

Personal precautions

Wear personal protective equipment.

Environmental precautions

Do not flush into surface water or sanitary sewer system. Do not allow material

to contaminate ground water system. Do not contaminate surface water.

Methods for cleaning up

Clean up promptly by scoop or vacuum. Use approved industrial vacuum

cleaner for removal. Small amounts: Clean up promptly by sweeping or vacuum.

7. HANDLING AND STORAGE

Handling

Advice on safe handling

Provide appropriate exhaust ventilation at places where dust is formed. In case

of insufficient ventilation, wear suitable respiratory equipment. Wear personal

protective equipment. Avoid dust formation in confined areas.

Advice on protection

against fire and explosion

Keep away from heat and sources of ignition.

Print date: 2005 - 2 - 10

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

Storage

Requirements for storage

areas and containers

Keep containers tightly closed in a dry, cool and well-ventilated place. Store in a

place accessible by authorized persons only. Keep out of the reach of children.

Advice on common storage

No materials to be specially mentioned.

8. EXPOSURE CONTROLS / PERSONAL PROTECTION

Components with workplace control parameters

Components

CAS-No.

Type

Control

parameters

Update

Basis

CYCLOHEXANONE

108-94-1

STEL

TWA (8 & 12 hr)

TWA (STEL 15

min)

102 mg/m3

408 mg/m3

2001

2001

EH40 OES

EH40 OES

DUPONT

DUPONT

Engineering measures

Ensure adequate ventilation, especially in confined areas.

Personal protective equipment

Respiratory protection

Respirator with combination filter for vapour/particulate.

Hand protection

Material: nitrile rubber

Glove thickness: 0,4 - 0,7 mm

Wearing time: 480 min

Please observe the instructions regarding permeability and breakthrough time

which are provided by the supplier of the gloves. Also take into consideration the

specific local conditions under which the product is used, such as the danger of

cuts, abrasion, and the contact time.

Eye protection

face-shield tightly fitting safety goggles

Skin and body protection

complete suit protecting against chemicals

Hygiene measures

Wash hands before breaks and immediately after handling the product. Keep

away from food, drink and animal feedingstuffs. When using, do not eat, drink or

smoke. Do not breathe dust. Avoid contact with skin, eyes and clothing.

Protective measures

Do not breathe dust. All chemical protective clothing should be visually

inspected prior to use. Clothing and gloves should be replaced in case of

chemical or physical damage or if contaminated.

9. PHYSICAL AND CHEMICAL PROPERTIES

Form

solid, granular,

Print date: 2005 - 2 - 10

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

Colour

blue green,

Odour

slight, solvent,

6,8 at 100 g/l ( 24 °C)

Flash point

not applicable

Explosive properties

Not explosive

Bulk density

720 kg/m3

Water solubility

229 g/l at 25 °C

10. STABILITY AND REACTIVITY

Hazardous decomposition

products

: Carbon oxides, nitrogen oxides (NOx)

Hazardous reactions

: Dust may form explosive mixture in air. No decomposition if stored and applied

as directed.

11. TOXICOLOGICAL INFORMATION

Acute oral toxicity

LD50/rat male: 43 mg/kg

LD50/rat female: 34 mg/kg

Acute inhalation toxicity

LC50/4 h/rat : 0,68 mg/l

Acute dermal toxicity

LD50/rabbit : > 5 000 mg/kg

Skin irritation

rabbit

No skin irritation

Skin irritation

CYCLOHEXANONE

rabbit

Result: No skin irritation Method: OECD Test Guideline 404

Eye irritation

rabbit

No eye irritation

Eye irritation

CYCLOHEXANONE

rabbit

Result: Moderate eye irritation

Sensitization

guinea pig Did not cause sensitization on laboratory animals.

Sensitization

Print date: 2005 - 2 - 10

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

CYCLOHEXANONE

guinea pig Result: Animal test did not cause sensitization by skin contact.

Repeated dose toxicity

CYCLOHEXANONE

Oral rat, Exposure time: 175 d, NOEL: 300 mg/kg

12. ECOLOGICAL INFORMATION

Elimination information (persistence and degradability)

Biodegradability

According to the results of tests of biodegradability this product is considered as

being readily biodegradable.

Ecotoxicity effects

Toxicity to fish

LC50/96 h/Rainbow trout: 36 mg/l

LC50/96 h/Bluegill sunfish: 47 mg/l

Toxicity to fish

CYCLOHEXANONE

LC50/96 h/Fathead minnow: 527 mg/l

Toxicity to algae

EC50/72 h/selenastrum capricornutum: 31 mg/l

Aquatic toxicity

EC50/48 h/Daphnia: 3,3 mg/l

Aquatic toxicity

CYCLOHEXANONE

EC50/24 h/Daphnia: 800 mg/l

13. DISPOSAL CONSIDERATIONS

Product

In accordance with local and national regulations. Must be incinerated in a

suitable incineration plant holding a permit delivered by the competent

authorities. Do not contaminate ponds, waterways or ditches with chemical or

used container.

Contaminated packaging

Do not re-use empty containers.

14. TRANSPORT INFORMATION

ADR

Class:

Packaging group:

Print date: 2005 - 2 - 10

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

Classification Code:

HI No::

UN-No:

2757

Labelling No.:

Proper shipping name:

CARBAMATE PESTICIDE, SOLID, TOXIC (Oxamyl)

IATA_C

Class:

Packaging group:

UN-No:

2757

Labelling No.:

Proper shipping name:

Carbamate pesticide, solid, toxic (contains Oxamyl)

IMDG

Class:

Packaging group:

UN-No:

2757

Labelling No.:

Proper shipping name:

CARBAMATE PESTICIDE, SOLID, TOXIC (contains Oxamyl)

Marine pollutant:

Marine pollutant.

15. REGULATORY INFORMATION

Labelling according to EEC Directive

Symbol(s)

Toxic

Dangerous for the environment

Hazardous components:

Oxamyl

R-phrase(s)

R23/25

Toxic by inhalation and if swallowed.

R51/53

Toxic to aquatic organisms, may cause long-term adverse

effects in the aquatic environment.

S-phrase(s)

Keep out of reach of children.

Keep away from food, drink and animal feedingstuffs.

S20/21

When using, do not eat, drink or smoke.

This material and its container must be disposed of in a safe

way.

In case of insufficient ventilation, wear suitable respiratory

equipment.

In case of accident or if you feel unwell, seek medical advice

immediately (show label where possible).

Use appropriate containment to avoid environmental

contamination.

Exceptional labelling of

special preparations

To avoid risks to man and the environment, comply with the instructions for use.

Print date: 2005 - 2 - 10

SAFETY DATA SHEET

according to EC directive 2001/58/EC

VYDATE

®

10 G

Version 2.1

Revision Date 09.07.2004

Ref. 130000000049

16. OTHER INFORMATION

Text of R phrases mentioned in Section 2

Flammable.

Harmful by inhalation.

Harmful in contact with skin.

R26/28

Also very toxic by inhalation and if swallowed.

Causes burns.

Toxic to aquatic organisms.

May cause long-term adverse effects in the aquatic environment.

The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at

the date of its publication. The information given is designed only as a guidance for safe handling, use, processing,

storage, transportation, disposal and release and is not to be considered a warranty or quality specification. The

information relates only to the specific material designated and may not be valid for such material used in

combination with any other materials or in any process, unless specified in the text.

Print date: 2005 - 2 - 10

  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.



  • Dokumenter på andre sprog er tilgængelige her

17-10-2018

Applicability of in silico tools for the prediction of dermal absorption for pesticides

Applicability of in silico tools for the prediction of dermal absorption for pesticides

Published on: Tue, 16 Oct 2018 00:00:00 +0200 Based on the “Human in vitro dermal absorption datasets” published as supporting information to the revised EFSA Guidance on Dermal Absorption, in silico models for prediction of absorption across the skin have been evaluated. For this evaluation, a systematic literature search and review was performed, identifying 288 publications describing mathematical models for prediction of dermal absorption. Eleven models potentially relevant to the regulatory assessm...

Europe - EFSA - European Food Safety Authority Publications

11-10-2018

Re‐evaluation of oxidised soya bean oil interacted with mono‐ and diglycerides of fatty acids (E 479b) as a food additive

Re‐evaluation of oxidised soya bean oil interacted with mono‐ and diglycerides of fatty acids (E 479b) as a food additive

Published on: Wed, 10 Oct 2018 00:00:00 +0200 The EFSA Panel on Food Additives and Flavourings (FAF) provides a scientific opinion re‐evaluating the safety of thermally oxidised soya bean oil interacted with mono‐ and diglycerides of fatty acids (TOSOM) (E 479b) when used as a food additive. The Scientific Committee on Food (SCF) and the Joint FAO/WHO Expert Committee on Food Additives (JECFA) derived an acceptable daily intake (ADI) of 25 and 30 mg/kg body weight (bw) per day, respectively. There was n...

Europe - EFSA - European Food Safety Authority Publications

11-10-2018

Wild boar in focus: Review of existing models on spatial distribution and density of wild boar and proposal for next steps

Wild boar in focus: Review of existing models on spatial distribution and density of wild boar and proposal for next steps

Published on: Wed, 10 Oct 2018 00:00:00 +0200 This report provides a review of existing models for predicting the spatial distribution and abundance of wild boar at various scales (global, continental, national and regional) in order to inform the development of a new model to produce estimates of wild boar abundance at European level. The review identifies and discusses a range of models based on a wide variety of data types, corresponding to those targeted by the data collection model set by ENETwild,...

Europe - EFSA - European Food Safety Authority Publications

10-10-2018

Sprayology Issues Voluntary Nationwide Recall of Homeopathic Aqueous-Based Medicines Due to Microbial Contamination

Sprayology Issues Voluntary Nationwide Recall of Homeopathic Aqueous-Based Medicines Due to Microbial Contamination

Eight and Company LLC, d/b/a Sprayology is voluntarily recalling all lots within expiry from 10/18-7/22 of its aqueous-based homeopathic product line for human use. All products manufactured by the contract manufacturer, King Bio, have been recalled due to possible microbial contamination.

FDA - U.S. Food and Drug Administration

10-10-2018

Enforcement Report for the Week of October 10, 2018

Enforcement Report for the Week of October 10, 2018

Recently Updated Records for the Week of October 10, 2018 Last Modified Date: Tuesday, October 09, 2018

FDA - U.S. Food and Drug Administration

24-9-2018

FDA Announces Availability of Resources for Animal Drug Sponsors

FDA Announces Availability of Resources for Animal Drug Sponsors

The FDA is making available two pre-recorded webinars and a slide presentation to help drug sponsors understand recent changes to the submission process for new animal drug applications and related submissions. The changes take effect 10/1/2018.

FDA - U.S. Food and Drug Administration

19-9-2018

National dietary survey in 2012‐2016 on the general population aged 1‐79 years in the Netherlands

National dietary survey in 2012‐2016 on the general population aged 1‐79 years in the Netherlands

Published on: Tue, 18 Sep 2018 00:00:00 +0200 During the years 2012‐2016, the Dutch National Food Consumption survey was conducted in the Netherlands. For the survey, a random sample was drawn from consumer panels stratified by age and gender and maintained representative to the population with regard to region, address density and educational level. Complete results were obtained for 4,313 persons (response rate 65%); including toddlers, children, adolescents, adults and elderly. Pregnant or lactating ...

Europe - EFSA - European Food Safety Authority Publications

13-9-2018

October 10, 2018: Meeting of the Oncologic Drugs Advisory Committee

October 10, 2018: Meeting of the Oncologic Drugs Advisory Committee

October 10, 2018: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement

FDA - U.S. Food and Drug Administration

11-9-2018

Peer review of the pesticide risk assessment of the active substance alpha‐cypermethrin

Peer review of the pesticide risk assessment of the active substance alpha‐cypermethrin

Published on: Mon, 10 Sep 2018 00:00:00 +0200 The conclusions of EFSA following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State Belgium and co‐rapporteur Member State Greece for the pesticide active substance alpha‐cypermethrin are reported. The context of the peer review was that required by Commission Implementing Regulation (EU) No 844/2012. The conclusions were reached on the basis of the evaluation of the representative uses of...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Update of the Xylella spp. host plant database

Update of the Xylella spp. host plant database

Published on: Mon, 10 Sep 2018 00:00:00 +0200 Following a request from the European Commission, EFSA periodically updates the database on the host plants of Xylella spp. While previous editions of the database (2015 and 2016) dealt with the species Xylella fastidiosa only, this database version addresses the whole genus Xylella, including therefore both species X. fastidiosa and Xylella taiwanensis. The database now includes information on host plants of Xylella spp. retrieved from scientific literature...

Europe - EFSA - European Food Safety Authority Publications

10-9-2018

USDA and FDA announce joint public meeting on use of animal cell culture technology to develop products derived from livestock and poultry

USDA and FDA announce joint public meeting on use of animal cell culture technology to develop products derived from livestock and poultry

WASHINGTON, Sept. 10, 2018 – U.S. Secretary of Agriculture Sonny Perdue, DVM and U.S. Food and Drug Administration Commissioner Scott Gottlieb, M.D. today announced a joint public meeting to be held on Oct. 23-24, 2018 to discuss the use of cell culture technology to develop products derived from livestock and poultry.

FDA - U.S. Food and Drug Administration

7-9-2018

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to Product/Label Mix-Up

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to Product/Label Mix-Up

Camber Pharmaceuticals, Inc. is voluntarily recalling one single lot of Montelukast Sodium Tablets, USP 10mg, to the consumer level. This recall of one batch of Montelukast Sodium Tablets, USP 10mg, lot# MON17384 Exp. 12/31/2019, was prompted because a complaint of a sealed bottle labeled as Montelukast 10mg 30 ct found to contain 90 tablets of Losartan Potassium Tablets, USP 50mg

FDA - U.S. Food and Drug Administration

1-9-2018

Spodoptera frugiperda partial risk assessment

Spodoptera frugiperda partial risk assessment

Published on: Fri, 31 Aug 2018 00:00:00 +0200 EFSA was asked for a partial risk assessment of Spodoptera frugiperda for the territory of the EU focussing on the main pathways for entry, factors affecting establishment, risk reduction options and pest management. As a polyphagous pest, five commodity pathways were examined in detail. Aggregating across these and other pathways, we estimate that tens of thousands to over a million individual larvae could enter the EU annually on host commodities. Instigat...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Outcome of the public consultation on a draft protocol for the Scientific Opinion on dietary sugars

Outcome of the public consultation on a draft protocol for the Scientific Opinion on dietary sugars

Published on: Fri, 10 Aug 2018 00:00:00 +0200 The European Food Safety Authority (EFSA) carried out a public consultation to receive input from the scientific community and all interested parties on a draft protocol for the Scientific Opinion on free sugars from all dietary sources, prepared by the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA Panel), supported by the ad‐hoc Working Group on Sugars. The draft protocol was endorsed by the Panel for public consultation at its plenary meeti...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Safety assessment of the process ‘General Plastic’, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials

Safety assessment of the process ‘General Plastic’, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials

Published on: Fri, 10 Aug 2018 00:00:00 +0200 This scientific opinion of the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF Panel) deals with the safety evaluation of the recycling process General Plastic (EU register No RECYC153), which is based on the Starlinger Decon technology. The decontamination efficiency of the process was demonstrated by a challenge test. The input of this process is hot caustic washed and dried poly(ethylene terephthalate) (PET) flakes orig...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Protocol for the scientific opinion on the Tolerable Upper Intake Level of dietary sugars

Protocol for the scientific opinion on the Tolerable Upper Intake Level of dietary sugars

Published on: Fri, 10 Aug 2018 00:00:00 +0200 In June 2016, EFSA received a mandate from the national food competent authorities of five European countries (Denmark, Finland, Iceland, Norway and Sweden) to provide a dietary reference value (DRV) for sugars, with particular attention to added sugars. A draft protocol was developed with the aim of defining as much as possible beforehand the strategy that will be applied for collecting data, appraising the relevant evidence, and analysing and integrating t...

Europe - EFSA - European Food Safety Authority Publications

22-8-2018

Radagast Pet Food Voluntarily Expands Recall to Include Rad Cat Raw Diet Products With Best By Dates of 10/19/18 Through 12/3/19 Due to Potential Health Risk

Radagast Pet Food Voluntarily Expands Recall to Include Rad Cat Raw Diet Products With Best By Dates of 10/19/18 Through 12/3/19 Due to Potential Health Risk

Radagast Pet Food, Inc. of Portland, OR is expanding its voluntary recall to include an additional quantity of Rad Cat Raw Diet across all varieties with Best By dates of 10/19/18 through 12/3/19 because it has the potential to be contaminated with Listeria monocytogenes. Radagast Pet Food is conducting this voluntary recall out of an abundance of caution because of its strong commitment to food safety and quality.

FDA - U.S. Food and Drug Administration

10-8-2018

Enforcement Report for the Week of July 25, 2018

Enforcement Report for the Week of July 25, 2018

Recently Updated Records for the Week of July 25, 2018 Last Modified Date: Friday, August 10, 2018

FDA - U.S. Food and Drug Administration

18-7-2018

Orphan designation:  Recombinant humanised anti-human interleukin-1 beta monoclonal antibody,  for the: Treatment of Behçet’s disease

Orphan designation: Recombinant humanised anti-human interleukin-1 beta monoclonal antibody, for the: Treatment of Behçet’s disease

On 1 October 2010, orphan designation (EU/3/10/796) was granted by the European Commission to XOMA Ireland Ltd, Ireland, for recombinant humanised anti-human interleukin-1 beta monoclonal antibody for the treatment of Behçet’s disease.

Europe - EMA - European Medicines Agency

12-7-2018

July 10, 2018: Pawtucket Woman Sentenced for Participation in Opioid Prescription Conspiracy

July 10, 2018: Pawtucket Woman Sentenced for Participation in Opioid Prescription Conspiracy

July 10, 2018: Pawtucket Woman Sentenced for Participation in Opioid Prescription Conspiracy

FDA - U.S. Food and Drug Administration

11-7-2018

July 10, 2018: VA Medical Center Nurse Indicted, Arraigned for Allegedly Tampering with and Stealing Prescription Opioids

July 10, 2018: VA Medical Center Nurse Indicted, Arraigned for Allegedly Tampering with and Stealing Prescription Opioids

July 10, 2018: VA Medical Center Nurse Indicted, Arraigned for Allegedly Tampering with and Stealing Prescription Opioids

FDA - U.S. Food and Drug Administration

11-7-2018

July 10, 2018: Former Des Moines Pharmacy Technician Sentenced for Illegally Tampering with Fentanyl

July 10, 2018: Former Des Moines Pharmacy Technician Sentenced for Illegally Tampering with Fentanyl

July 10, 2018: Former Des Moines Pharmacy Technician Sentenced for Illegally Tampering with Fentanyl

FDA - U.S. Food and Drug Administration

26-9-2018

Kexxtone (Elanco GmbH)

Kexxtone (Elanco GmbH)

Kexxtone (Active substance: Monensin sodium) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)6324 of Wed, 26 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/2235/T/10

Europe -DG Health and Food Safety

19-9-2018

Lartruvo (Eli Lilly Nederland B.V.)

Lartruvo (Eli Lilly Nederland B.V.)

Lartruvo (Active substance: olaratumab) - Centralised - Annual renewal - Commission Decision (2018)6105 of Wed, 19 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4216/R/10

Europe -DG Health and Food Safety

19-9-2018

Pregabalin Mylan (Mylan S.A.S.)

Pregabalin Mylan (Mylan S.A.S.)

Pregabalin Mylan (Active substance: pregabalin) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018) 5971 of Wed, 19 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4078/T/10

Europe -DG Health and Food Safety

10-9-2018

Akynzeo (Helsinn Birex Pharmaceuticals Ltd)

Akynzeo (Helsinn Birex Pharmaceuticals Ltd)

Akynzeo (Active substance: netupitant / palonosetron) - Centralised - Yearly update - Commission Decision (2018)5947 of Mon, 10 Sep 2018

Europe -DG Health and Food Safety

10-9-2018

Alkindi (Diurnal Limited)

Alkindi (Diurnal Limited)

Alkindi (Active substance: hydrocortisone) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5945 of Mon, 10 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4416/T/03

Europe -DG Health and Food Safety

10-9-2018

Retacrit (Hospira UK Limited)

Retacrit (Hospira UK Limited)

Retacrit (Active substance: epoetin zeta) - Centralised - Yearly update - Commission Decision (2018)5946 of Mon, 10 Sep 2018

Europe -DG Health and Food Safety

10-9-2018

Silapo (STADA Arzneimittel AG)

Silapo (STADA Arzneimittel AG)

Silapo (Active substance: epoetin zeta) - Centralised - Yearly update - Commission Decision (2018)5944 of Mon, 10 Sep 2018

Europe -DG Health and Food Safety

4-9-2018

ACM meeting statement, Meeting 10, 2 August 2018

ACM meeting statement, Meeting 10, 2 August 2018

The Advisory Committee on Medicines meeting statement is now available

Therapeutic Goods Administration - Australia

22-8-2018

BTVPUR (Merial)

BTVPUR (Merial)

BTVPUR (Active substance: Bluetongue virus vaccine (inactivated) (multistrain: 1-2 strains out of a set of 4)) - Centralised - 2-Monthly update - Commission Decision (2018)5630 of Wed, 22 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/2231/II/10

Europe -DG Health and Food Safety

10-8-2018

Torisel (Pfizer Europe MA EEIG)

Torisel (Pfizer Europe MA EEIG)

Torisel (Active substance: Temsirolimus) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5521 of Fri, 10 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/799/T/71

Europe -DG Health and Food Safety

10-8-2018

Brinavess (Correvio)

Brinavess (Correvio)

Brinavess (Active substance: vernakalant hydrochloride) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5523 of Fri, 10 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/1215/T/31

Europe -DG Health and Food Safety

10-8-2018

Lymphoseek (Norgine B.V.)

Lymphoseek (Norgine B.V.)

Lymphoseek (Active substance: tilmanocept) - Centralised - Yearly update - Commission Decision (2018)5520 of Fri, 10 Aug 2018

Europe -DG Health and Food Safety

10-8-2018

Sivextro (Merck Sharp and Dohme B.V.)

Sivextro (Merck Sharp and Dohme B.V.)

Sivextro (Active substance: tedizolid phosphate) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5522 of Fri, 10 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2846/T/28

Europe -DG Health and Food Safety

10-8-2018

Cubicin (Merck Sharp and Dohme B.V.)

Cubicin (Merck Sharp and Dohme B.V.)

Cubicin (Active substance: Daptomycin) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5519 of Fri, 10 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/637/T/69

Europe -DG Health and Food Safety

10-8-2018

Thalidomide Celgene (Celgene Europe B.V.)

Thalidomide Celgene (Celgene Europe B.V.)

Thalidomide Celgene (Active substance: Thalidomide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5524 of Fri, 10 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/823/T/57

Europe -DG Health and Food Safety

10-8-2018

CANCIDAS (Merck Sharp and Dohme B.V.)

CANCIDAS (Merck Sharp and Dohme B.V.)

CANCIDAS (Active substance: caspofungin) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5517 of Fri, 10 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/379/T/67

Europe -DG Health and Food Safety

10-8-2018

Tesavel (Merck Sharp and Dohme B.V.)

Tesavel (Merck Sharp and Dohme B.V.)

Tesavel (Active substance: sitagliptin) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5518 of Fri, 10 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/910/T/65

Europe -DG Health and Food Safety

10-8-2018

Januvia (Merck Sharp and Dohme B.V.)

Januvia (Merck Sharp and Dohme B.V.)

Januvia (Active substance: sitagliptin) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)4511 of Fri, 10 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/722/T/65

Europe -DG Health and Food Safety

10-8-2018

Bortezomib Hospira (Pfizer Europe MA EEIG)

Bortezomib Hospira (Pfizer Europe MA EEIG)

Bortezomib Hospira (Active substance: bortezomib) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5515 of Fri, 10 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4207/T/10

Europe -DG Health and Food Safety

7-8-2018

By Aug. 10, all packages and advertisements for “covered” tobacco products (except for cigars and pipe tobacco) and roll-your-own/cigarette tobacco products must have the required nicotine warning statement. https://cards.twitter.com/cards/2m2m96/5xn98 …

By Aug. 10, all packages and advertisements for “covered” tobacco products (except for cigars and pipe tobacco) and roll-your-own/cigarette tobacco products must have the required nicotine warning statement. https://cards.twitter.com/cards/2m2m96/5xn98 …

By Aug. 10, all packages and advertisements for “covered” tobacco products (except for cigars and pipe tobacco) and roll-your-own/cigarette tobacco products must have the required nicotine warning statement. https://cards.twitter.com/cards/2m2m96/5xn98 …

FDA - U.S. Food and Drug Administration

7-8-2018

Memantine Accord (Accord Healthcare Limited)

Memantine Accord (Accord Healthcare Limited)

Memantine Accord (Active substance: memantine) - Centralised - Renewal - Commission Decision (2018)5421 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2766/R/10

Europe -DG Health and Food Safety

30-7-2018

Zalmoxis (MolMed S.p.A.)

Zalmoxis (MolMed S.p.A.)

Zalmoxis (Active substance: Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (?LNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2)) - Centralised - Renewal - Commission Decision (2018)5118 of Mon, 30 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2801/R/10

Europe -DG Health and Food Safety

27-7-2018

EU/3/11/868 (Celgene Europe B.V.)

EU/3/11/868 (Celgene Europe B.V.)

EU/3/11/868 (Active substance: Lenalidomide) - Transfer of orphan designation - Commission Decision (2018)5045 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/160/10/T/01

Europe -DG Health and Food Safety

13-7-2018

Briviact (UCB Pharma S.A.)

Briviact (UCB Pharma S.A.)

Briviact (Active substance: brivaracetam) - Centralised - 2-Monthly update - Commission Decision (2018)4715 of Fri, 13 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3898/II/10/G

Europe -DG Health and Food Safety